Global Infection Control & Biosafety Products Markets, 2018-2019 & 2023 - Products, Current/Forecast Markets, Competitors, and Opportunities - ResearchAndMarkets.com

DUBLIN--()--The "Infection Control and Biosafety Products" report has been added to ResearchAndMarkets.com's offering.

Each year, healthcare-associated infections (HAIs) affect nearly 700,000 people in the US and 4.5 million in Europe, resulting in billions of dollars in direct and indirect healthcare costs. The viral diseases covered by this report (hepatitis B, hepatitis C, and HIV) account for nearly 365 million infections globally (nearly 8.5 million in the US, five major EU markets, and Japan).

From an infection control perspective, sterile-packaged single-patient-use (SPU) products offer the best assurance of avoiding infection; however, due to pricing pressures as a result of managed care, facilities must evaluate their mix of SPU and reusable devices.

In 2018, combined global sales of the injection devices covered by this analysis totaled $2.7bn, with safety needles and syringes accounting for nearly 90% of sales; this share is expected to increase over the forecast period as the trend toward sharps with safety features continues.

This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the HAI prevention products and services market (medical waste disposal products and services, SPU medical device reprocessing systems, sharps disposal products, and sterilization equipment and services), injection devices market (standard and safety needles and syringes), and viral and bacterial diagnostic products market.

Countries covered include the US, five major EU markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of World markets, for the years 2018-23.

Companies Mentioned

  • Becton Dickinson
  • Cardinal Health
  • Smiths Medical/Smiths Group

Key Topics Covered

Executive Summary

i. HAI prevention products and services

ii. Injection devices and related products

Exhibit ES-1: Injection devices, market forecast ($m), by product type, 2018-23

iii. Viral and bacterial diagnostic products

Exhibit ES-2: Bacterial infections, disease facts, latest year available

Exhibit ES-3: Viral infections, disease prevalence, 2018

iv. Methodology

1. Healthcare-Associated Infection Prevention Products and Services

1.1 Medical waste disposal products and services

1.1.1 Competitors

1.2 Single patient use medical device reprocessing services

1.2.1 Competitors

1.3 Other HAI prevention products and services

1.3.1 Sharps disposal containers

1.3.2 Sterilization equipment, services, and supplies

1.4 Bibliography

2. Injection Devices

2.1 Overview

2.2 Regulations and guidelines

2.3 Needlestick prevention

2.4 Standard disposable needles and syringes

2.4.1 Market analysis

Exhibit 2-1: Standard disposable needles and syringes, market forecast ($m), by region, 2018-23

2.4.2 Competitive analysis

Becton Dickinson

Exhibit 2-2: Becton Dickinson, revenues by segment, 2018

Cardinal Health

Exhibit 2-3: Cardinal Health, revenues by segment, 2018

Smiths Medical/Smiths Group

Exhibit 2-4: Smiths Group, revenues by segment, 2018

Other suppliers

Exhibit 2-5: Standard disposable needles and syringes market, share by supplier, 2018

2.5 Safety needles and syringes

2.5.1 Market analysis

Exhibit 2-6: Safety needles and syringes, market forecast ($m), by region, 2018-23

2.5.2 Competitive analysis

Exhibit 2-7: Safety needles and syringes market, share by supplier, 2018

2.6 Combined market forecast

Exhibit 2-8: Injection devices, combined market forecast ($m), by product type, 2018-23

2.7 Bibliography

3. Viral and Bacterial Diagnostic Products

3.1 Bacterial infectious disease diagnosis

Exhibit 3-1: Bacterial infections, disease facts, latest year available

3.1.1 Clostridium difficile

3.1.2 Pneumonia

3.1.3 Staphylococcus aureus

3.1.4 Tuberculosis

3.2 Viral infectious disease diagnosis

Exhibit 3-2: Viral infections, disease prevalence, 2018

3.2.1 Hepatitis B

3.2.2 Hepatitis C

3.2.3 Human immunodeficiency virus

3.3 Bibliography

Appendix A: Company Listing

For more information about this report visit https://www.researchandmarkets.com/r/lb5mid

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Disease Testing

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Disease Testing